Impact of Antimicrobial Stewardship Program on Vancomycin Usage: Costs and Outcomes at Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam

Nowadays, with the emergence of vancomycin-resistant strains, the clinical use of vancomycin has been followed closely by applying the antimicrobial stewardship program (ASP) to enhance effectiveness in treatment and reduce cost burden for patients. A descriptive cross-sectional study at the Hospita...

Full description

Saved in:
Bibliographic Details
Published in:Risk management and healthcare policy 2021-01, Vol.14, p.2637-2646
Main Authors: Nguyen-Thi, Hai-Yen, Nguyen, Duy-Anh, Huynh, Phuong-Thao, Le, Nguyen Dang Tu
Format: Article
Language:English
Subjects:
Antibiotic resistance
Antibiotics
Antimicrobial agents
antimicrobial stewardship program
Clinical medicine
Computers
Costs
Drug dosages
Drug resistance in microorganisms
Economic aspects
Generalized linear models
Gram-positive bacteria
hospital for tropical diseases
Hospitals
Medical care, Cost of
Medical research
Medicine, Experimental
Mortality
Original Research
outcomes
Patients
Services
Streptococcus infections
treatment costs
Tropical diseases
Vancomycin
vietnam
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nowadays, with the emergence of vancomycin-resistant strains, the clinical use of vancomycin has been followed closely by applying the antimicrobial stewardship program (ASP) to enhance effectiveness in treatment and reduce cost burden for patients. A descriptive cross-sectional study at the Hospital for Tropical Diseases was conducted to assess the inpatient status assigned to intravenous vancomycin and factors associated with the cost of treatment during two periods of implementing ASP, which were i) from April 1, 2016 to March 31, 2018 (previous ASP-pASP) and ii) from June 1, 2018 to March 31, 2020 (new ASP-nASP). Among 1375 patients who met the sampling criteria, there were 601 and 774 patients in pASP and nASP, respectively. The rate of no improvement/mortality in the pASP was higher than that in nASP (37.10% vs 25.98%, p
ISSN:1179-1594
1179-1594
DOI:10.2147/RMHP.S307744